Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices

Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices

Left-ventricular assist devices (LVADs) improve outcomes in end-stage heart failure patients. Two centrifugal-flow LVAD systems are currently approved, HeartMate 3 (HM3) and Medtronic/Heartware HVAD (HVAD). Clinical findings suggest differences in thrombogenicity between both systems. We compared ma...

Full description

Bibliographic Details
Main Authors:	Maximilian Tscharre, Franziska Wittmann, Daniela Kitzmantl, Silvia Lee, Beate Eichelberger, Patricia P. Wadowski, Günther Laufer, Dominik Wiedemann, Birgit Forstner-Bergauer, Cihan Ay, Simon Panzer, Daniel Zimpfer, Thomas Gremmel
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-02-01
Series:	Platelets
Subjects:	lvad heartmate 3 hvad platelet activation platelet aggregation
Online Access:	http://dx.doi.org/10.1080/09537104.2021.1881950

Similar Items

Use of Intracorporeal Durable LVAD Support in Children Using HVAD or HeartMate 3—A EUROMACS Analysis
by: Martin Schweiger, et al.
Published: (2023-08-01)

What happens when a disruptive technology gets disrupted?
by: Lauren E. Meece, et al.
Published: (2021-06-01)

Growth Differentiation Factor-15 Correlates Inversely with Protease-Activated Receptor-1-Mediated Platelet Reactivity in Patients with Left Ventricular Assist Devices
by: Maximilian Tscharre, et al.
Published: (2022-04-01)

Third‐generation continuous‐flow left ventricular assist devices: a comparative outcome analysis by device type
by: Maks Mihalj, et al.
Published: (2022-10-01)

Commentary: Cost-Effectiveness of Left Ventricular Assist Devices as Destination Therapy in the United Kingdom
by: Priyansh Faldu, et al.
Published: (2022-07-01)

Apixaban in bridge to transplant and destination LVAD ‐ rationale and study design: the ApixiVAD trial
by: Bruno Schnegg, et al.
Published: (2024-08-01)

Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States
by: Teruhiko Imamura, et al.
Published: (2020-03-01)

Totally percutaneous endovascular repair of HeartMate 3 ventricular assistive device outflow graft pseudoaneurysm
by: Mark D. Balceniuk, MD, MPH, et al.
Published: (2020-12-01)

Maintaining a Bloodless Field for HeartMate 3 Placement: Splicing an RVAD Outflow Cannula into the CPB Venous Reservoir for Complete LV Emptying
by: Justin W. Walker, et al.
Published: (2024-10-01)

Echocardiographic haemodynamic monitoring in the context of HeartMate 3™ therapy: a systematic review
by: Linus Ohlsson, et al.
Published: (2024-08-01)

Monitoring pulmonary pressures during long‐term continuous‐flow left ventricular assist device and fixed pulmonary hypertension: redefining alleged pathophysiological mechanisms?
by: Chantal C. De Bakker, et al.
Published: (2020-04-01)

Pericardial release for early LVAD malalignment a less invasive approach
by: Eric I. Jeng, et al.
Published: (2021-03-01)

HeartWare HVAD: Postoperative issues in our first patient
by: Sarvesh Pal Singh, et al.
Published: (2017-01-01)

Underlying mechanism and specific prevention of hemolysis-induced platelet activation
by: Thomas Gremmel, et al.
Published: (2017-08-01)

Implantable devices: a bridge to heart transplantation
by: D. Zimpfer, et al.
Published: (2019-01-01)

Chest radiographs of cardiac devices (Part 2): Ventricular assist devices
by: Rishi P. Mathew, et al.
Published: (2019-07-01)

Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis
by: Ksenia Brusilovskaya, et al.
Published: (2022-08-01)

Surgical Outcomes of Centrifugal Continuous-Flow Implantable Left Ventricular Assist Devices: Heartmate 3 versus Heartware Ventricular Assist Device
by: Kinam Shin, et al.
Published: (2024-03-01)

Protease‐activated receptor‐mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors
by: Patricia P. Wadowski, et al.
Published: (2019-07-01)

Corrigendum: Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry
by: Alessandra Francica, et al.
Published: (2023-10-01)

Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry
by: Alessandra Francica, et al.
Published: (2023-09-01)

Prospective Evaluation of Feline Sourced Platelet-Rich Plasma Using Centrifuge-Based Systems
by: Jonathan T. Ferrari, et al.
Published: (2020-06-01)

Endovascular stenting of an HVAD™ outflow graft pseudoaneurysm that exerts compression and kinking stenosis on the soft portion of the prosthesis
by: Mohamed Elbayomi, et al.
Published: (2023-05-01)

Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
by: Stefan Stojkovic, et al.
Published: (2020-12-01)

Impact of diabetes on platelet activation in different manifestations of atherosclerosis
by: Thomas Gremmel, et al.
Published: (2013-05-01)

Long-term outcomes after percutaneous withdrawal of HeartWare left ventricular assist device (HVAD) support: A 10-year update
by: Chokanan Thaitirarot, et al.
Published: (2025-02-01)

Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure –1 year results from the Ce mark trial
by: Thomas Krabatsch, et al.
Published: (2017-04-01)

A Prospective Observational Study on Multiplate®-, ROTEM®- and Thrombin Generation Examinations Before and Early After Implantation of a Left Ventricular Assist Device (LVAD)
by: Philipp Opfermann, et al.
Published: (2022-02-01)

Optimisation of a double-centrifugation method for preparation of canine platelet-rich plasma
by: Hyeok-Soo Shin, et al.
Published: (2017-06-01)

Controller and battery changes due to technical problems related to the HVAD® left ventricular assist device - a single center experience
by: Emil Najjar, et al.
Published: (2018-06-01)

Does Double Centrifugation Lead to Premature Platelet Aggregation and Decreased TGF-β1 Concentrations in Equine Platelet-Rich Plasma?
by: Sarah R. T. Seidel, et al.
Published: (2019-08-01)

Evaluation of activation characteristics of a canine platelet concentrate produced by a commercial double centrifugation system
by: Nicole Tey, et al.
Published: (2024-05-01)

Driveline Features as Risk Factor for Infection in Left Ventricular Assist Devices: Meta-Analysis and Experimental Tests
by: Melanie Kranzl, et al.
Published: (2021-12-01)

Impact of diastolic pulmonary gradient and pulmonary vascular remodeling on survival after left ventricular assist device implantation and heart transplantation
by: Mohamed Laimoud, et al.
Published: (2023-12-01)

Pressure‐dimension index and left ventricular sphericity index following HeartMate II and HeartMate 3 implantation
by: Luisa Schnoering, et al.
Published: (2024-10-01)

The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane
by: David M. Dohan Ehrenfest, et al.
Published: (2018-02-01)

Comparison of the effects of platelet concentrates produced by high and low-speed centrifugation protocols on the healing of critical-size defects in rat calvaria: a microtomographic and histomorphometric study
by: Lucia Moitrel Pequeno da Silva, et al.
Published: (2022-11-01)

Toll-like Receptors as Pro-Thrombotic Drivers in Viral Infections: A Narrative Review
by: Benjamin Panzer, et al.
Published: (2023-07-01)

Toward the Relevance of Platelet Subpopulations for Transfusion Medicine
by: Stefan Handtke, et al.
Published: (2018-02-01)

Fibrinogen Concentrations in Liquid PRF Using Various Centrifugation Protocols
by: Zahra Kargarpour, et al.
Published: (2022-03-01)